Elisabeth Kaza, D.Sc., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiomegaly | 1 | 2010 | 620 | 0.300 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2010 | 552 | 0.300 |
Why?
|
| Capillaries | 1 | 2010 | 773 | 0.300 |
Why?
|
| Neovascularization, Physiologic | 2 | 2012 | 1351 | 0.290 |
Why?
|
| Mitral Valve | 1 | 2011 | 1491 | 0.220 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2011 | 1422 | 0.200 |
Why?
|
| Myocardium | 1 | 2010 | 4776 | 0.150 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2011 | 3537 | 0.140 |
Why?
|
| Umbilical Cord | 1 | 2016 | 180 | 0.130 |
Why?
|
| Cysts | 1 | 2016 | 678 | 0.100 |
Why?
|
| Heart Septal Defects | 1 | 2011 | 192 | 0.090 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2011 | 364 | 0.090 |
Why?
|
| Ligation | 1 | 2010 | 453 | 0.090 |
Why?
|
| Pregnancy Proteins | 1 | 2010 | 229 | 0.090 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2012 | 638 | 0.080 |
Why?
|
| Fontan Procedure | 1 | 2014 | 778 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 546 | 0.080 |
Why?
|
| Rabbits | 2 | 2012 | 4894 | 0.080 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2012 | 859 | 0.070 |
Why?
|
| Myocardial Contraction | 1 | 2011 | 1585 | 0.070 |
Why?
|
| Animals, Newborn | 1 | 2010 | 2726 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3870 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4751 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2010 | 5179 | 0.050 |
Why?
|
| Aorta | 1 | 2010 | 2061 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2010 | 4217 | 0.050 |
Why?
|
| Heart Transplantation | 1 | 2014 | 3110 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2010 | 3508 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2010 | 8436 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2011 | 3670 | 0.040 |
Why?
|
| Boston | 1 | 2011 | 9313 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2010 | 5985 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2016 | 25625 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2010 | 13033 | 0.030 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2014 | 264 | 0.030 |
Why?
|
| Angiostatins | 1 | 2012 | 67 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2014 | 41006 | 0.030 |
Why?
|
| Endostatins | 1 | 2012 | 174 | 0.030 |
Why?
|
| Collagen Type IV | 1 | 2012 | 140 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 18029 | 0.020 |
Why?
|
| Aging | 1 | 2010 | 8664 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 2014 | 936 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2011 | 23338 | 0.020 |
Why?
|
| Time Factors | 1 | 2011 | 40075 | 0.020 |
Why?
|
| Infant | 1 | 2011 | 35136 | 0.020 |
Why?
|
| Pressure | 1 | 2012 | 1203 | 0.020 |
Why?
|
| Autoantigens | 1 | 2012 | 892 | 0.020 |
Why?
|
| Child | 2 | 2014 | 77709 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2014 | 77449 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2011 | 63114 | 0.020 |
Why?
|
| Risk Factors | 1 | 2011 | 72290 | 0.020 |
Why?
|
| Animals | 2 | 2012 | 168757 | 0.010 |
Why?
|
| Male | 2 | 2016 | 350118 | 0.010 |
Why?
|
| Humans | 3 | 2016 | 744343 | 0.010 |
Why?
|
| Female | 1 | 2011 | 380194 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 56430 | 0.000 |
Why?
|
| Adolescent | 1 | 2014 | 85781 | 0.000 |
Why?
|
| Adult | 1 | 2014 | 214055 | 0.000 |
Why?
|